Oren Shuster

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany

Oren Shuster Recent News

War In Gaza Forces Israel To Delay Medical Cannabis Reform
The Israel Ministry of Health announced the anticipated reform of medical cannabis regulations
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Monday for the period ending June 30, 2023.
These Companies Are Ready To Capitalize On Latest Marijuana Reforms In Israel And Germany
Cannabis companies in the U.S. and Canada are capitalizing on the expanding European market as attitudes toward cannabis products continue to evolve and regulatory frameworks become more favorable.
IM Cannabis Q1 Revenue Stagnates YoY, Here Is What You Need To Know
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of CA$13.2 million ($9.8 million) compared to CA$13 million in the first quarter of 2022, an increase of 1%.
IM Cannabis FY22 Revenue From Continuing Operations Grows 60% To $54.3M
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) FY 2022 revenues from continuing operations were CA$54.3 million, an increase of 60% compared to CA$34.1 million in 2021.
IM Cannabis To Reduce Its Workforce In Israel By Up To 25%
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) will be reducing its workforce in Israel by 20%-25% across all functions to strengthen its focus on core activities and drive efficiencies to realize sustainable profitability.
IM Cannabis Secures $500K Via Private Placement Lead By Oren Shuster And Rafael Gabay
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) has closed the first tranche of its non-brokered private placement, of 400,000 units of the company at a price of $1.25 per unit for aggregate proceeds of $500,000
IM Cannabis To Raise Up To $5.5M Via Private Placement Offerings
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) announced a non-brokered private placement of a minimum of 400,000 units and a maximum of 2.96 million units of the company at a price of $1.25 per unit for aggregate gros
Avant & IM Cannabis Team Up To Bring New Medical Marijuana Products To Israel
Avant Brands Inc. (TSX: AVNT) (OTC-QX: AVTBF) (FRA: 1BU0) and IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) jointly announced on Wednesday the signing of an international trademark licensing agreement granting IMC the exclusive right to launch the BLKMKT brand in the Israeli medical
IM Cannabis To Raise Up To $5M Via Private Placement Led By Management
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) is undertaking a non-brokered private placement for aggregate gross proceeds of up to $5 million.
IM Cannabis Q2 Revenue Grows 114% YoY, What About Profit?
IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for its second quarter ended June 30, 2022, revealing revenues increased 114% year-over-year to CA$23.8 million ($18.43 million). Q2 2022 Financial Results
IM Cannabis Reports Record First Quarter 2022 Financial Results, Revenues Increase 169% YoY To $23.6M
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical and adult-use cannabis company with operations in Israel, Canada, and Germany, announced its financial results on Thursday for the three months ended March 31, 2022 (Q1).
EXCLUSIVE: International Cannabis Companies Share Solutions For Global Expansion
As the business of cannabis grows in size and opportunity, many companies in the space are wondering about the challenges of international expansion.
IM Cannabis Revenue In 2021 Grows 242% to $43.38M
IM Cannabis Closes Acquisition Of Israel's Medical Marijuana Oranim Pharm
IM Cannabis Closes Three Strategic Acquisitions In Israel Valued Around $11.77M
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) has completed three strategic acquisitions.
IM Cannabis Q4 Revenues To Increase 308% YoY, Positioned To Capture Market Growth In Israel
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) has reported its preliminary unaudited financial results for the three months and fiscal year ended December 31, 2021.
IM Cannabis Imports 400 Kilos Of Premium Indoor-Grown Dried Cannabis From Canada To Israel
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) announced on Wednesday that Focus Medical Herbs Ltd.
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
IM Cannabis Corp. (CSE: IMCC), (NASDAQ: IMCC) will acquire the majority of Jerusalem’s leading medical cannabis pharmacy, Oranim. The cannabis company confirmed Wednesday that its Israeli subsidiary IMC Holdings Ltd.
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
IM Cannabis Corp.
IM Cannabis Q3 Revenue Grows 30% Sequentially To $11.5M
IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%.
IM Cannabis Reports 192% YoY Spike In Q2 2021 Revenue, Purchases Stake In Vironna Pharm
Multi-country medical and recreational cannabis operator IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) reported its unaudited financial results on Monday for the three- and six-month periods ended June 30.
cbdMD Stock Trading Down After Announcing Deal With IM Cannabis Corp. To Enter Israel
Cannabidiol brand cbdMD, Inc. (NYSE: YCBD) has teamed up with IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) to enter the Israeli market.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved